In the BioHarmony Drug Report Database

"Preview" Icon

Plecanatide

Trulance (plecanatide) is a protein pharmaceutical. Plecanatide was first approved as Trulance on 2017-01-19. It is used to treat constipation in the USA. It is known to target heat-stable enterotoxin receptor. Trulance immediate release’s patents are valid until 2034-06-05 (FDA).

 

Trade Name

 

Trulance
 

Common Name

 

plecanatide
 

ChEMBL ID

 

CHEMBL2103867
 

Indication

 

constipation
 

Drug Class

 

Peptides

Image (chem structure or protein)

Plecanatide structure rendering